Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNNI3K | Q59H18 | 14/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.40 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 3/20 | 0.38 |
| ▸ | BRAF | P15056 | 5/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9985447 | 0.91 | CDK2 (0.47) | TNNI3KCCNB2CDK1CCNB1CCNA2 | |
| SCHEMBL9986144 | 0.86 | TNNI3K (0.41) | TNNI3KCCNB2CDK1CCNB1CCNA2 | |
| SCHEMBL9987082 | 0.81 | TNNI3K (0.43) | TNNI3KBRAF | |
| SCHEMBL9985709 | 0.79 | TNNI3K (0.45) | TNNI3KBRAF | |
| SCHEMBL9985668 | 0.79 | TNNI3K (0.44) | TNNI3KBRAF | |
| SCHEMBL9986945 | 0.78 | TNNI3K (0.49) | TNNI3KBRAF | |
| SCHEMBL9986569 | 0.78 | TNNI3K (0.45) | TNNI3KBRAF | |
| SCHEMBL9987104 | 0.77 | TNNI3K (0.46) | TNNI3KBRAF | |
| SCHEMBL9985780 | 0.77 | TNNI3K (0.43) | TNNI3KBRAF | |
| SCHEMBL9985735 | 0.77 | TNNI3K (0.46) | TNNI3KBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011149827-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2011-12-01 | — | — | WO | claimed |
| WO-2011149827-A1 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2011-12-01 | — | — | WO | disclosed |